A Case Study of the Evolving Software Architecture for the FDA Generic Drug Application Process
AUTOR(ES)
Canfield, Kip
FONTE
American Medical Informatics Association
RESUMO
This primary goal of this project was to develop a software architecture to support the Food and Drug Administration (FDA) generic drug application process by making it more efficient and effective. The secondary goal was to produce a scalable, modular, and flexible architecture that could be generalized to other contexts in interorganizational health care communications. The system described here shows improvements over the old system for the generic drug application process for most of the defined design objectives. The modular, flexible design that produced this new system offers lessons for the general design of distributed health care information systems and points the way to robust application frameworks that will allow practical development and maintenance of a distributed infrastructure.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=61324Documentos Relacionados
- A software architecture process for SOA-based enterprise applications
- FDA: Evidentiary Standards for Drug Development and Approval
- Arquitetura de processo aplicada na integração de fábricas de software.
- Architecture for generic detection of machine code injection in computer networks
- FDA wins spoof award for its “collusion” with the drug industry